GoverMedia Plus Canada Corp. is a Canadian holding company with a fully owned Russian technology subsidiary. GoverMedia has developed a fully operational state of the art internet platform offering all-inclusive online services such as, e-commerce, social media, multimedia, corporate auctions, corporate database, messaging platform and crowdfunding services. We believe the GoverMedia platform is the first and only internet platform offering such a wide range of online services accessible via only one account. The Company’s management and advisors have extensive expertise in the Telecommunications, High-Technology, Corporate Development and Finance fields.

Hero Innovation Group Inc. (formerly, Euro Asia Pay Holdings Inc.) is a developer of innovative financial solutions for the next generation of consumers.  Hero Financials, the Company’s latest product, is targeted at parents, kids and young adults across Canada. With financial literacy at the forefront of the company’s values and a plethora of advanced proprietary technology features, Hero Financials prepares kids to become financially smart adults through a variety of financial literacy tools.

Disruptive patented detonation technology for manufacturing hydrogen and high-quality graphene in bulk that does not require external heat like conventional processes.

Imagin Medical is Building a Best-in-Class Urologic Oncology Company Developing technologies to better visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery

The Company believes its first product, the i/Blue Imaging System™, with its advanced proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease.

Imagin’s follow-on product, the enCAGE Coil™ is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.

After receipt of FDA clearance, Imagin believes the enCAGE Coil system for Prostate Cancer will address the limitations of current forms of treatment by enabling the surgeon to preset precise margins to target only the cancer cells, avoiding damage to the remaining prostate gland and surrounding erectile nerves that can impair urinary and sexual function.

Imagin’s proprietary technologies are poised to expand patient access and improve outcomes and quality of life.